Neutrolin, a catheter drug that helps prevent infection, biofilm and thrombosis in ICU and blood dialysis patients, won QIDP designation from the FDA. The chart has responded positively.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
